Cytokeratin 7 and 20 expression in choroid plexus tumors: Utility in differentiating these neoplasms from metastatic carcinomas

Modern Pathology

Volumn 13, Issue 6, 2000, Pages 638-643

  Gyure, Kymberly A ^a,c   Morrison, Alan L ^a,b  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Choroid plexus tumors; Cytokeratin 20; Cytokeratin 7; Immunohistochemistry

Indexed keywords

ANTIBODY; CYTOKERATIN 20; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NERVE CELL ADHESION MOLECULE; PREALBUMIN; PROTEIN S 100; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOROID PLEXUS TUMOR; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

EID: 0033932661     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880111     Document Type: Article

References (39)

1. Lantos PL, Vandenberg SR, Kleihues P. Tumors of the nervous system. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Arnold; 1997. p. 647-53.
2. Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro-Oncology 1999;1:14-25.
3. Ajir F, Chanbusarakum K, Bolles JC. Acinar choroid plexus adenoma of the fourth ventricle. Surg Neurol 1982;17:290-2.
4. Davis RL, Fox GE. Acinar choroid plexus adenoma: case report. J Neurosurg 1970;33:587-90.
5. Duckett S, Osterholm J, Schaefer D, Gonzales C, Schwartzman RJ. Ossified mucin-secreting choroid plexus adenoma: case report. Neurosurgery 1991;29:130-2.
6. Eljamel MSM, Jeffreys RV. Mucous-secreting choroid plexus adenoma-case report and review of the literature. Neuropediatrics 1990;21:55-6.
7. Diengdoh JV, Shaw MDD. Oncocytic variant of choroid plexus papilloma: evolution from benign to malignant "oncocytoma." Cancer 1993;71:855-8.
8. Stefanko SZ, Vuzevski VD. Oncocytic variant of choroid plexus papilloma. Acta Neuropathol 1985;66:160-2.
9. Reimund EL, Sitton JE, Harkin JC. Pigmented choroid plexus papilloma. Arch Pathol Lab Med 1990;114:902-5.
10. Boesel CP, Suhan JP. A pigmented choroid plexus carcinoma: histochemical and ultrastructural studies. J Neuropathol Exp Neurol 1979;38:177-86.
11. Andreini L, Doglioni C, Giangaspero F. Tubular adenoma of choroid plexus: a case report. Clin Neuropathol 1991;10:137-40.
12. Cardozo J, Cepeda F, Quintero M, Mora E. Choroid plexus papilloma containing bone. Acta Neuropathol 1985;68:83-5.
13. Salazar J, Vaquero J, Aranda IF, Menèndez J, Jimenez MD, Bravo G. Choroid plexus papilloma with chondroma: case report. Neurosurgery 1986;18:781-3.
14. Ang LC, Taylor AR, Bergin D, Kaufmann JCE. An immunohistochemical study of papillary tumors in the central nervous system. Cancer 1990;65:2712-9.
15. Coffin CM, Wick MR, Braun JT, Dehner LP. Choroid plexus neoplasms: clinicopathologic and immunohistochemical studies. Am J Surg Pathol 1986;10:394-404.
16. Cruz-Sanchez FF, Rossi ML, Hughes JT, Coakham HB, Figols J, Eynaud PM. Choroid plexus papillomas: an immunohistological study of 16 cases. Histopathology 1989;15:61-9.
17. Doglioni C, Dell'Orto P, Coggi G, Iuzzolino P, Bontempini L, Viale G. Choroid plexus tumors: an immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol 1987;127:519-29.
18. Furness PN, Lowe J, Tarrant GS. Subepithelial basement membrane deposition and intermediate filament expression in choroid plexus neoplasms and ependymomas. Histopathology 1990;16:251-5.
19. Kouno M, Kumanishi T, Washiyama K, Sekiguchi K, Saito T, Tanaka R. An immunohistochemical study of cytokeratin and glial fibrillary acidic protein in choroid plexus papilloma. Acta Neuropathol 1988;75:317-20.
20. Mannoji H, Becker LE. Ependymal and choroid plexus tumors: cytokeratin and GFAP expression. Cancer 1988;61: 1377-85.
21. Matsushima T, Inoue T, Takeshita I, Fukui M, Iwaki T, Kitamoto T. Choroid plexus papillomas: an immunohistochemical study with particular reference to the coexpression of prealbumin. Neurosurgery 1988;23:384-9.
22. Miettinen M, Clark R, Virtanen I. Intermediate filament proteins in choroid plexus and ependyma and their tumors. Am J Pathol 1986;123:231-40.
23. Paulus W, Jänisch W. Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases. Acta Neuropathol 1990;80:635-41.
24. Rubinstein LJ, Brucher J-M. Focal ependymal differentiation in choroid plexus papillomas: an immunoperoxidase study. Acta Neuropathol 1981;53:29-33.
25. Taratuto AL, Molina H, Monges J. Choroid plexus tumors in infancy and childhood. Focal ependymal differentiation: an immunoperoxidase study. Acta Neuropathol 1983;59:304-8.
26. Gottschalk J, Jautzke G, Paulus W, Goebel S, Cervos-Navarro J. The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas. Cancer 1993;72: 1343-9.
27. Kepes JJ, Collins J. Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol 1999; 58:398-401.
28. Albrecht S, Rouah E, Becker LE, Bruner J. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases. Mod Pathol 1991;4:610-4.
29. Herbert J, Cavallaro T, Dwork AJ. A marker for primary choroid plexus neoplasms. Am J Pathol 1990;136:1317-25.
30. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994;102:764-7.
31. Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996;9:1040-4.
32. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995;3:99-107.
33. Perry A, Parisi JE, Kurtin PJ. Metastatic adenocarcinoma to the brain: an immunohistochemical approach. Hum Pathol 1997;28:938-43.
34. Burger PC, Scheithauer BW. Tumors of neuroglia and choroid plexus epithelium. Tumors of the central nervous system. Vol. 10. Washington, DC: Armed Forces Institute of Pathology; 1994. p. 136-42.
35. Bratthauer GL, Adams LR. Immunohistochemistry: antigen detection in tissue. In: Mikel UV, editor. Advanced laboratory methods in histology and pathology. Washington, DC: Armed Forces Institute of Pathology; 1994. p. 1-40.
36. Miettinen M. Keratin immunohistochemistry: update of applications and pitfalls. Pathol Annu 1993;28:113-43.
37. Ramaekers F, van Niekerk C, Poels L, Schaafsma E, Huijsmans A, Robben H, et al. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol 1990;136:641-55.
38. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995;8:384-8.
39. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992;140:427-47.